← Back to Search

Project MARS: Mobile-Assistance for Regulating Smoking

N/A
Waitlist Available
Led By Inbal Nahum-Shani, PhD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-quit date - 6-month follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial will help researchers understand how to better help smokers quit by identifying when they are most vulnerable to lapse and most receptive to quitting aids.

Eligible Conditions
  • Tobacco Smoking
  • Smokers

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-quit date - 6-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-quit date - 6-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Biochemically Verified Smoking Abstinence

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Effortful self-regulatory activitiesExperimental Treatment5 Interventions
Group II: Brief cognitive/behavioral strategiesExperimental Treatment4 Interventions
Group III: No activitiesActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of MichiganOTHER
1,863 Previous Clinical Trials
6,441,419 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,958 Previous Clinical Trials
41,112,468 Total Patients Enrolled
University of UtahLead Sponsor
1,147 Previous Clinical Trials
1,698,968 Total Patients Enrolled
Inbal Nahum-Shani, PhDPrincipal InvestigatorUniversity of Michigan
1 Previous Clinical Trials
400 Total Patients Enrolled
David Wetter, PhDPrincipal Investigator - University of Utah
University of Utah
1 Previous Clinical Trials
200 Total Patients Enrolled
~21 spots leftby Jan 2026